Search Results for: manufacturer

June 6, 2025June 6, 2025

Postmarket Safety Surveillance of FDA-Cleared Prescription Digital Therapeutics Using the Manufacturer and User Facility Device Experience (MAUDE) Database: A Pharmacovigilance Study.

Publication date: Jun 01, 2025 Background and aim Prescription digital therapeutics (PDTs) are software-based medical treatments authorized by the U. S. Food and Drug Administration (FDA) for a range of ... Read more

May 26, 2025

COVID-19 pandemic: A multidimensional analysis and the strategic role played by developing countries vaccine manufacturers.

Coronavirus Literature

Publication date: May 23, 2025 Contribution of Developing Countries Vaccine Manufacturers (DCVMs) in the vaccine response to the COVID-19 pandemic crisis in 2021-2022 has been paramount, totaling 9. 81 billion ... Read more

June 4, 2025

Believing FDA’s Assurance of Quality Pharmaceutical Products Can Be Dangerous to Your Patients’ Health.

Coronavirus Literature

Publication date: Jun 03, 2025 The Food and Drug Administration (FDA) exists to protect US consumers. However, while drug manufacturing has shifted dramatically to developing countries like India and China, ... Read more

June 2, 2025

Esketamine implementation challenges in psychiatry: A qualitative analysis of mental healthcare providers’ social media commentary

Major Depressive Disorder News

Publication date: May 31, 2025 Background Though esketamine was approved by the Food and Drug Administration (FDA) for treatment-resistant depression in 2019, there is no published research on implementation challenges. ... Read more

June 2, 2025June 2, 2025

Highly increasing solubility of clofazimine, an extremely water-insoluble basic drug, in lipid-based SEDDS using digestion products of long-chain lipids.

Tuberculosis Literature

Publication date: Jun 01, 2025 Clofazimine (CFZ) is a highly effective antibiotic against leprosy and drug-resistant tuberculosis and is on the WHO List of Essential Drugs. However, no CFZ product ... Read more

June 1, 2025June 1, 2025

Ultrasonic Neuromodulation Devices 2025: Disruptive Growth & Next-Gen Brain Therapies Unveiled

Parkinson's Disease News

Publication date: Jun 01, 2025 Secondary research involved the review of published clinical studies, regulatory filings, and annual reports from leading companies in the field. For example, INSIGHTEC Ltd. has ... Read more

May 26, 2025May 26, 2025

FDA Requires Randomized Controlled Trial Data for COVID-19 Vaccines Targeting Healthy Populations

Coronavirus News

Publication date: May 26, 2025 Under the new requirements, vaccine manufacturers must now provide robust clinical trial data demonstrating safety and efficacy through randomized, controlled studies. The changes aim to ... Read more

May 24, 2025May 24, 2025

Comparable immune escape capacity between KP.2 and other SARS-CoV-2 variants in the central Chinese population after the first COVID-19 booster.

Coronavirus Literature

Publication date: May 22, 2025 The neutralisation ability of homologous and heterologous booster vaccinations against the KP. 2 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unknown. Therefore, ... Read more

May 16, 2025

Functional improvement as a treatment goal in major depressive disorder: a narrative review of the evidence for vortioxetine.

Major Depressive Disorder Literature

Publication date: May 15, 2025 This narrative review used manufacturer-sponsored vortioxetine clinical trial database (doses of 5-20 mg) to evaluate the effect of vortioxetine treatment on short- and long- term functional ... Read more

May 16, 2025

COVID-19 vaccine coverage among adults in Sarlahi District of Nepal in 2022.

Coronavirus Literature

Publication date: May 15, 2025 Nepal launched its COVID-19 vaccination campaign in January 2021 through the COVID-19 Vaccines Global Access (COVAX) facility. Vaccine coverage, especially in low- and middle-income countries ... Read more